Numerous exciting studies that advanced our understanding of immune-mediated kidney disease were published in 2018. Whereas most of these studies analysed the role of pro-inflammatory mediators, several novel anti-inflammatory mechanisms were discovered that involve immune cells and mediators with previously unrecognized protective roles in renal disease.
Key advances
-
Glomerular podocytes reside in an immune-privileged site and so are protected from cytotoxic T lymphocytes (CTLs); disruption of Bowman’s capsule during glomerulonephritis renders podocytes susceptible to killing by CTLs2.
-
Fibrocytes are important producers of collagen for the repair of mechanical kidney injury, but can also contribute to renal fibrosis during chronic inflammation6.
-
Renal resident type 2 innate lymphoid cells (ILC2s) exert a potent protective function in renal ischaemia–reperfusion injury by producing amphiregulin and inducing M2 polarization8.
-
The pro-inflammatory cytokine macrophage migration inhibitory factor (MIF) also has anti-inflammatory effects that protect kidney tubular cells after ischaemia–reperfusion injury and rhabdomyolysis9.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The podocytes’ inflammatory responses in experimental GN are independent of canonical MYD88-dependent toll-like receptor signaling
- Thomas Schömig
- , Paul Diefenhardt
- …Sebastian Brähler
Scientific Reports Open Access 27 January 2024
-
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
- Baowei Ji
- , Junchao Liu
- …Jian Yu
Cell Death & Disease Open Access 09 September 2023
-
Signaling pathways of chronic kidney diseases, implications for therapeutics
- Qian Yuan
- , Ben Tang
- &Chun Zhang
Signal Transduction and Targeted Therapy Open Access 09 June 2022
Access options
Change institution
Buy or subscribe
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 /30days
cancel any time
Learn more
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Learn more
Prices may be subject to local taxes which are calculated during checkout
References
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A. & Smith, K. G. C. T cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523, 612–616 (2015).
Chen, A. et al. Bowman’s capsule provides a protective niche for podocytes from cytotoxic CD8+ T cells. J. Clin. Invest. 128, 3413–3424 (2018).
Heymann, F. et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J. Clin. Invest. 119, 1286–1297 (2009).
Goldwich, A. et al. Podocytes are nonhematopoietic professional antigen-presenting cells. J. Am. Soc. Nephrol. 24, 906–916 (2013).
Niedermeier, M. et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc. Natl Acad. Sci. USA 106, 17892–17897 (2009).
Buchtler, S. et al. Cellular origin and functional relevance of collagen I production in the kidney. J. Am. Soc. Nephrol. 29, 1859–1873 (2018).
Riedel, J. H. et al. IL-33-mediated expansion of type 2 innate lymphoid cells protects from progressive glomerulosclerosis. J. Am. Soc. Nephrol. 28, 2068–2080 (2017).
Cao, Q. et al. Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury. J. Am. Soc. Nephrol. 29, 961–976 (2018).
CAS PubMed Google Scholar
Stoppe, C. et al. The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery. Sci. Transl Med. 10, eaan4886 (2018).
Djudjaj, S. et al. Macrophage migration inhibitory factor mediates proliferative GN via CD74. J. Am. Soc. Nephrol. 27, 1650–1664 (2016).
Acknowledgements
The authors’ work was supported by the Deutsche Forschungsgemeinschaft grants SFB1192 (C.K. and C.M.S.) and SFBTR57 (C.K.), and by the European Union’s Horizon 2020 research and innovation programme, grant no. 668036- RELENT (C.K.).
Author information
Authors and Affiliations
Institute of Experimental Immunology, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany
Christian Kurts
Institute of Cellular and Integrative Physiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany
Catherine Meyer-Schwesinger
Authors
- Christian Kurts
View author publications
You can also search for this author in PubMedGoogle Scholar
- Catherine Meyer-Schwesinger
View author publications
You can also search for this author in PubMedGoogle Scholar
Corresponding authors
Correspondence to Christian Kurts or Catherine Meyer-Schwesinger.
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Kurts, C., Meyer-Schwesinger, C. Protecting the kidney against autoimmunity and inflammation. Nat Rev Nephrol 15, 66–68 (2019). https://doi.org/10.1038/s41581-018-0097-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-018-0097-0
This article is cited by
-
The podocytes’ inflammatory responses in experimental GN are independent of canonical MYD88-dependent toll-like receptor signaling
- Thomas Schömig
- Paul Diefenhardt
- Sebastian Brähler
Scientific Reports (2024)
-
Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis
- Baowei Ji
- Junchao Liu
- Jian Yu
Cell Death & Disease (2023)
-
Design of therapeutic biomaterials to control inflammation
- Zhaoxu Tu
- Yiling Zhong
- Kam W. Leong
Nature Reviews Materials (2022)
-
Signaling pathways of chronic kidney diseases, implications for therapeutics
- Qian Yuan
- Ben Tang
- Chun Zhang
Signal Transduction and Targeted Therapy (2022)